|
1
|
Kaseb AO, Xiao L, Naguib R, El-Shikh W,
Hassan M, Hassabo H, Lee JH, Yoon JH, Lee HS, Chae YK, et al:
Abstract C26: Development and validation of a scoring system using
insulin-like growth factor to assess hepatic reserve in
hepatocellular carcinoma. Mol Cancer Ther. 12:(Suppl 11). C262013.
View Article : Google Scholar
|
|
2
|
Arzumanyan A, Reis HM and Feitelson MA:
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular
carcinoma. Nat Rev Cancer. 13:123–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aoki T, Kokudo N, Matsuyama Y, Izumi N,
Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, et al:
Liver Cancer Study Group of Japan: Prognostic impact of spontaneous
tumor rupture in patients with hepatocellular carcinoma: An
analysis of 1160 cases from a nationwide survey. Ann Surg.
259:532–542. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llovet JM, Peña CE, Lathia CD, Shan M,
Meinhardt G and Bruix J: SHARP Investigators Study Group: Plasma
biomarkers as predictors of outcome in patients with advanced
hepatocellular carcinoma. Clin Cancer Res. 18:2290–2300. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jordán F, Nguyen TP and Liu WC: Studying
protein-protein interaction networks: A systems view on diseases.
Brief Funct Genomics. 11:497–504. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Doncheva NT, Kacprowski T and Albrecht M:
Recent approaches to the prioritization of candidate disease genes.
Wiley Interdiscip Rev Syst Biol Med. 4:429–442. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kulkarni H, Göring HHH, Diego V, Cole S,
Walder KR, Collier GR, Blangero J and Carless MA: Association of
differential gene expression with imatinib mesylate and omacetaxine
mepesuccinate toxicity in lymphoblastoid cell lines. BMC Med
Genomics. 5:372012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McCormick KP, Willmann MR and Meyers BC:
Experimental design, preprocessing, normalization and differential
expression analysis of small RNA sequencing experiments. Silence.
2:22011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choi CH, Choi JJ, Park YA, Lee YY, Song
SY, Sung CO, Song T, Kim MK, Kim TJ, Lee JW, et al: Identification
of differentially expressed genes according to chemosensitivity in
advanced ovarian serous adenocarcinomas: Expression of GRIA2
predicts better survival. Br J Cancer. 107:91–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lucas SM and Heath EI: Current challenges
in development of differentially expressed and prognostic prostate
cancer biomarkers. Prostate Cancer. 2012:6409682012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anglani R, Creanza TM, Liuzzi VC, Piepoli
A, Panza A, Andriulli A and Ancona N: Loss of connectivity in
cancer co-expression networks. PLoS One. 9:e87075. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
de la Fuente A: From ‘differential
expression’ to ‘differential networking’ - identification of
dysfunctional regulatory networks in diseases. Trends Genet.
26:326–333. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bockmayr M, Klauschen F, Györffy B,
Denkert C and Budczies J: New network topology approaches reveal
differential correlation patterns in breast cancer. BMC Syst Biol.
7:782013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cornella H, Alsinet C, Sayols S, Zhang Z,
Hao K, Cabellos L, Hoshida Y, Villanueva A, Thung S, Ward SC, et
al: Unique genomic profile of fibrolamellar hepatocellular
carcinoma. Gastroenterolog. 148:806–818. 2015. View Article : Google Scholar
|
|
15
|
Mah WC, Thurnherr T, Chow PK, Chung AY,
Ooi LL, Toh HC, Teh BT, Saunthararajah Y and Lee CG: Methylation
profiles reveal distinct subgroup of hepatocellular carcinoma
patients with poor prognosis. PLoS One. 9:e1041582014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e15. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bolstad B: affy: Built-in Processing
Methods. 2013.https://www.bioconductor.org/packages/devel/bioc/vignettes/affy/inst/doc/builtinMethods.pdf
|
|
19
|
Allen JD, Wang S, Chen M, Girard L, Minna
JD, Xie Y and Xiao G: Probe mapping across multiple microarray
platforms. Brief Bioinform. 13:547–554. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sims AH, Smethurst GJ, Hey Y, Okoniewski
MJ, Pepper SD, Howell A, Miller CJ and Clarke RB: The removal of
multiplicative, systematic bias allows integration of breast cancer
gene expression datasets - improving meta-analysis and prediction
of prognosis. BMC Med Genomics. 1:422008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Asness CS, Moskowitz TJ and Pedersen LH:
Value and momentum everywhere. J Finance. 68:929–985. 2013.
View Article : Google Scholar
|
|
22
|
Wang J: Pearson correlation
coefficientEncyclopedia of Systems Biology. Dubitzky W, Wolkenhauer
O, Cho KH and Yokota H: Springer; New York, NY: pp. 16712013,
View Article : Google Scholar
|
|
23
|
Gayen AK: The frequency distribution of
the product-moment correlation coefficient in random samples of any
size drawn from non-normal universes. Biometrika. 38:219–247. 1951.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McHugh ML: The chi-square test of
independence. Biochem Med Zagreb. 23:143–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Agresti A: Categorical Data Analysis. 1st.
John Wiley & Sons; New York, NY: 1996
|
|
26
|
Simas AB and Cordeiro GM: Adjusted Pearson
residuals in exponential family nonlinear models. J Stat Comput
Simul. 79:411–425. 2009. View Article : Google Scholar
|
|
27
|
Dolinski K and Botstein D: Automating the
construction of gene ontologies. Nat Biotechnol. 31:34–35. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: The Gene Ontology Consortium: Gene ontology: Tool for the
unification of biology. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Croft D, O'Kelly G, Wu G, Haw R, Gillespie
M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, et al:
Reactome: a database of reactions, pathways and biological
processes. Nucleic Acids Res. 39:D691–D697. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kanehisa M, Goto S, Sato Y, Furumichi M
and Tanabe M: KEGG for integration and interpretation of
large-scale molecular data sets. Nucleic Acids Res. 40:D109–D114.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Upton GJ: Fisher's exact test. J R Stat
Soc Ser A Stat Soc. 155:395–402. 1992. View Article : Google Scholar
|
|
32
|
Bonferroni CE: Teoria statistica delle
classi e calcolo delle probabilita. Libreria internazionale Seeber.
1936.
|
|
33
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J R Stat Soc B. 57:289–300. 1995.
|
|
34
|
Lui TW, Tsui NB, Chan LW, Wong CS, Siu PM
and Yung BY: DECODE: An integrated differential co-expression and
differential expression analysis of gene expression data. BMC
Bioinformatics. 16:1822015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bryman A and Cramer D: Quantitative Data
Analysis with SPSS 12 and 13. Routledge; Hove, East Sussex:
2005
|
|
36
|
Haynes W: Student's t-TestEncyclopedia of
Systems Biology. Dubitzky W, Wolkenhauer O, Cho KH and Yokota H:
Springer; New York, NY: pp. 2023–2025. 2013, View Article : Google Scholar
|
|
37
|
Ladd JJ, Busald T, Johnson MM, Zhang Q,
Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati R, Feng Z,
et al: Increased plasma levels of the APC-interacting protein
MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer
in women. Cancer Prev Res (Phila). 5:655–664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stypula-Cyrus Y, Mutyal NN, Cruz M Dela,
Kunte DP, Radosevich AJ, Wali R, Roy HK and Backman V: End-binding
protein 1 (EB1) up-regulation is an early event in colorectal
carcinogenesis. FEBS Lett. 588:829–835. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu M, Yang S, Wang Y, Zhu H, Yan S, Zhang
W, Quan L, Bai J and Xu N: EB1 acts as an oncogene via activating
β-catenin/TCF pathway to promote cellular growth and inhibit
apoptosis. Mol Carcinog. 48:212–219. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Y, Zhou X, Zhu H, Liu S, Zhou C,
Zhang G, Xue L, Lu N, Quan L, Bai J, et al: Overexpression of EB1
in human esophageal squamous cell carcinoma (ESCC) may promote
cellular growth by activating β-catenin/TCF pathway. Oncogene.
24:6637–6645. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Taguchi A, Rho JH, Yan Q, Zhang Y, Zhao Y,
Xu H, Tripathi SC, Wang H, Brenner DE, Kucherlapati M, et al:
MAPRE1 as a plasma biomarker for early-stage colorectal cancer and
adenomas. Cancer Prev Res (Phila). 8:1112–1119. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ralhan R, Desouza LV, Matta A, Tripathi S
Chandra, Ghanny S, Gupta S Datta, Bahadur S and Siu KW: Discovery
and verification of head-and-neck cancer biomarkers by differential
protein expression analysis using iTRAQ labeling, multidimensional
liquid chromatography, and tandem mass spectrometry. Mol Cell
Proteomics. 7:1162–1173. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Orimo T, Ojima H, Hiraoka N, Saito S,
Kosuge T, Kakisaka T, Yokoo H, Nakanishi K, Kamiyama T, Todo S, et
al: Proteomic profiling reveals the prognostic value of adenomatous
polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
Hepatology. 48:1851–1863. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Waszczuk-Jankowska M, Markuszewski MJ,
Markuszewski M and Kaliszan R: Comparison of RP-HPLC columns used
for determination of nucleoside metabolic patterns in urine of
cancer patients. Bioanalysis. 4:1185–1194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Neef AB and Luedtke NW: An azide-modified
nucleoside for metabolic labeling of DNA. ChemBioChem. 15:789–793.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wahlström T and Henriksson MA: Impact of
MYC in regulation of tumor cell metabolism. Biochim Biophys Acta.
1849:563–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Laks DR, Ta L, Crisman TJ, Gao F, Coppola
G, Radu CG, Nathanson DA and Kornblum HI: Inhibition of nucleotide
synthesis targets brain tumor stem cells in a subset of
glioblastoma. Mol Cancer Ther. 15:1271–1278. 2016. View Article : Google Scholar : PubMed/NCBI
|
